Synthetic Biology in Agriculture Market Forecasts to 2032 - Global Analysis By Crop Type, Input Type, Mode of Deployment, Technology, Application, End User and By Geography

According to Stratistics MRC, the Global Synthetic Biology in Agriculture Market is accounted for $8.2 billion in 2025 and is expected to reach $82.7 billion by 2032 growing at a CAGR of 38.9% during the forecast period. Synthetic biology in agriculture is an interdisciplinary field that combines biology, engineering, and computational sciences to design and construct novel biological systems or modify existing organisms for agricultural purposes. It focuses on creating crops with enhanced traits such as improved yield, resistance to pests and diseases, drought tolerance, and optimized nutrient content. By engineering microorganisms, plants, and enzymes, synthetic biology can also improve soil health, enable sustainable fertilizer production, and develop bio-based pesticides. This approach aims to increase agricultural efficiency, reduce environmental impact, and support food security by harnessing precise, programmable biological solutions.

Market Dynamics:

Driver:

Rising demand for sustainable crop production

Farmers and agribusinesses are increasingly adopting synthetic biology solutions to reduce reliance on chemical inputs and enhance resource efficiency. Engineered seeds and microbial solutions enable higher yields while minimizing environmental impact, aligning with global sustainability goals. Growing consumer preference for eco-friendly food production further accelerates adoption of synthetic biology technologies. Governments and international organizations are promoting sustainable farming practices, reinforcing demand for innovative biological tools. The ability of synthetic biology to create resilient crops supports long-term food security.

Restraint:

Limited awareness among small-scale farmers

Many farmers remain unfamiliar with synthetic biology applications and their benefits, slowing adoption in fragmented agricultural systems. Lack of access to training and extension services further exacerbates this challenge. High complexity of technologies and perceived risks discourage smallholders from experimenting with engineered solutions. Limited awareness also restricts demand in emerging economies where traditional practices dominate. Without targeted education and outreach, adoption will remain concentrated among large-scale commercial farms.

Opportunity:

Growing need for pest-resistant crop varieties

Synthetic biology enables the development of engineered seeds and microbial traits that enhance resilience against pests and diseases. Rising crop losses due to climate change and evolving pest pressures are driving demand for such solutions. Farmers benefit from reduced pesticide use, lower costs, and improved productivity, reinforcing adoption. Advances in genetic engineering and CRISPR technologies are accelerating innovation in pest-resistant traits. Governments and research institutions are supporting development programs to strengthen food security.

Threat:

Ethical concerns over genetically modified crops

Consumer skepticism about genetic engineering and perceived risks to biodiversity limit acceptance in several regions. Advocacy groups often raise concerns about long-term ecological impacts, slowing regulatory approvals. Ethical debates around food safety and labeling further challenge market credibility. Public resistance in regions with strong organic and natural food movements creates barriers to adoption. These concerns also discourage investment in commercialization, particularly in markets with strict regulatory frameworks. Consequently, ethical issues surrounding genetically modified crops remain a critical threat to market growth.

Covid-19 Impact:

The COVID-19 pandemic had a mixed impact on the Synthetic Biology in Agriculture market. Supply chain disruptions delayed research projects and restricted access to engineered inputs, slowing adoption in several regions. Farmers faced financial uncertainty, reducing investment in advanced biological solutions during the crisis. However, the pandemic highlighted the importance of resilient and sustainable food systems, driving renewed interest in synthetic biology. Remote collaboration and digital platforms supported ongoing research and commercialization despite restrictions. Governments emphasized food security, accelerating funding for innovative agricultural technologies.

The engineered seeds & traits segment is expected to be the largest during the forecast period

The engineered seeds & traits segment is expected to account for the largest market share during the forecast period due to its ability to deliver high-yield and resilient crops. Synthetic biology enables precise genetic modifications that enhance nutrient efficiency, pest resistance, and climate adaptability. Farmers benefit from reduced input costs and improved productivity, reinforcing demand for engineered traits. The segment's dominance is further supported by strong investment from biotech firms and seed companies. Widespread adoption in commercial farming operations strengthens its market leadership. Rising demand for sustainable crop production aligns directly with the benefits of engineered seeds.

The seed treatment segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the seed treatment segment is predicted to witness the highest growth rate owing to enhanced crop resilience. Synthetic biology innovations in microbial coatings and bio-based treatments improve germination rates and protect against pests and diseases. Farmers are increasingly adopting seed treatments as cost-effective alternatives to chemical pesticides. Rising awareness of sustainable farming practices accelerates demand for bio-based seed solutions. Advances in biotechnology are enabling more effective and targeted treatments, strengthening adoption. The segment benefits from scalability and compatibility with diverse crop types.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share driven by advanced agricultural infrastructure. Farmers in the United States and Canada are leveraging synthetic biology to enhance productivity and sustainability. Strong presence of leading biotech firms and seed companies accelerates commercialization of engineered traits. Government support and regulatory frameworks provide relatively clearer guidance compared to other regions. High awareness of sustainable crop production further reinforces demand. Investment in research institutions and collaborations strengthens innovation pipelines.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR by rapid agricultural modernization. Countries such as China, India, and Australia are increasingly adopting synthetic biology to improve crop resilience. Expanding middle-class populations and increasing disposable incomes support premium product adoption. Government initiatives promoting sustainable farming and biotechnology further boost demand. Farmers in the region are becoming more aware of the benefits of pest-resistant and bio-based solutions. E-commerce and digital platforms are making synthetic biology products more accessible across diverse markets.

Key players in the market

Some of the key players in Synthetic Biology in Agriculture Market include Bayer AG, Corteva Agriscience, Syngenta Group, BASF SE, Novozymes, Ginkgo Bioworks, Pivot Bio, Indigo Agriculture, Benson Hill, Evogene, Zymergen, Amyris, Agrivida, GreenLight Biosciences and Tropic Biosciences.

Key Developments:

In February 2024, Corteva launched its novel Lumidax(R) biofungicide in Canada. This product, based on the proprietary Pseudomonas chlororaphis strain, exemplifies synthetic biology by using a naturally occurring bacterium to protect roots and leaves from major fungal diseases. This launch underscores Corteva's commitment to expanding its portfolio of effective, sustainable biological solutions for growers.

In October 2023, Bayer announced a significant €220 million investment to expand its Biologics Center of Excellence and the manufacturing site in West Sacramento, California. This expansion is specifically aimed at scaling up the production and development of its biological crop protection products, including those derived from synthetic biology partnerships.

Crop Types Covered:

• Cereals & Grains
• Oilseeds & Pulses
• Fruits & Vegetables
• Other Crop Types

Input Types Covered:

• Biofertilizers
• Biopesticides
• Engineered Seeds & Traits
• Synthetic Microbial Consortia
• Bio-Based Growth Regulators
• Other Input Types

Mode of Deployments Covered:

• Seed Treatment
• Soil Application
• Foliar Application
• Other Mode of Deployments

Technologies Covered:

• Genetic Engineering
• Genome Editing
• Synthetic Biology
• Other Technologies

Applications Covered:

• Water Efficiency Improvement
• Stress Tolerance Enhancement
• Precision Agriculture Support
• Crop Engineering
• Other Applications

End Users Covered:

• Large-Scale Commercial Farms
• Medium Farms
• Smallholder Farms
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances